跳至主要内容
临床试验/ChiCTR-OPC-14005353
ChiCTR-OPC-14005353进行中(未招募)治疗新技术临床试验

臨床試驗研究 –「自體間質幹細胞治療腕關節軟骨缺損」

The Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年10月1日最近更新:

试验速览

阶段
治疗新技术临床试验
状态
进行中(未招募)
入组人数
20
试验地点
1
主要终点
Diagnostic radiological (MRI)assessments will be done at post-injection 6th month.

研究概览

简要总结

自體間質幹細胞治療腕關節軟骨缺損

研究设计

研究类型
观察性研究
主要目的
单臂

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • Wrist pain of mechanical origin(post-traumatic);
  • The pain cannot be relieved by treating other underlying defects other than carpal affections;
  • Patients with imaging and previous arthroscopic evidence of wrist carpal bone chondral defects;
  • Absence of any local or general infection;
  • Hematologic and biochemical analyses with no significant alterations that contraindicate intervention;
  • Patient who is able to understand the nature the study and provide informed written consent.

排除标准

  • Age older than 75 or younger than 18 years old or legally dependent;
  • Patients with past history of hematologic disorders;
  • Signs of infection or positive serology for HIV, HBV, HCV, or syphilis;
  • Congenital or acquired diseases leading to significant wrist deformities that may interfere with cell application or interpretation of results;
  • Pregnancy or breast, feeding, Neoplasia, Immunosuppression, Participation in another clinical trial or treatment with another investigational product within 30 days before inclusion in the study;
  • Patients with alcoholism/drug abuse;
  • Other medical conditions that may discourage participation in the study.

研究组 & 干预措施

Case series

Autologous mesenchymal stem cell intra-articular injection

结局指标

主要结局

Diagnostic radiological (MRI)assessments will be done at post-injection 6th month.

次要结局

  • VAS, functional wrist score, PRWE, DASH, Power, ROM at post-injection 3rd, 6th, 12nd and 24th month

研究者

研究点 (1)

Loading locations...

相似试验